Wikidata

(Q61980943)

English

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
Risk Adapted Treatment of Newly Diagnosed Childhood Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide (Trisenox® IND# 103, 331) During Consolidation (English)
0 references
country
Canada
0 references
start time
March 2009
0 references
end time
June 2015
0 references
number of participants
108
0 references
research intervention
methotrexate
0 references
cytarabine
0 references
tretinoin
0 references
mitoxantrone
0 references
idarubicin
0 references
arsenic trioxide
0 references
research site
Kaiser Permanente
0 references
CancerCare Manitoba
0 references
Loma Linda University
0 references
Georgetown University
0 references
University of Kentucky
0 references
Tulane University
0 references
Mayo Clinic
0 references
UNM Los Lunas
0 references
Wake Forest University
0 references
Cleveland Clinic
0 references
IWK Health Centre
0 references
McMaster University
0 references
minimum age
2 year
0 references
maximum age
21 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61980943&oldid=2149382205"